Oncopeptides AB (publ) (LON:0RN4)

Oncopeptides AB Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	116	24	57	91	52	1,028
Market Cap Growth	420.86%	-57.28%	-37.99%	76.61%	-94.98%	80.91%
Enterprise Value	116	15	47	58	-3	917
Last Close Price	0.43	0.11	0.40	0.65	0.46	10.17
PS Ratio	23.57	10.58	20.58	137.15	5.35	-
PB Ratio	225.23	6.17	12.76	3.89	3.00	19.99
P/TBV Ratio	225.23	6.17	12.76	3.89	3.02	20.05
EV/Sales Ratio	23.37	6.38	17.01	86.70	-	-
Debt / Equity Ratio	22.75	2.61	2.31	0.02	0.07	0.03
Asset Turnover	0.24	0.13	0.11	0.02	0.17	-
Inventory Turnover	0.21	0.78	-	-	-	-
Quick Ratio	3.27	3.74	4.26	4.22	1.78	2.44
Current Ratio	3.42	4.23	4.52	4.25	1.83	2.53
Return on Equity (ROE)	-376.73%	-512.51%	-141.91%	-133.80%	-363.13%	-232.14%
Return on Assets (ROA)	-57.86%	-73.20%	-50.66%	-52.59%	-134.59%	-97.95%
Return on Capital (ROIC)	-75.21%	-91.97%	-64.70%	-82.55%	-227.14%	-134.96%
Return on Capital Employed (ROCE)	-158.10%	-146.50%	-130.70%	-115.80%	-697.10%	-256.70%
Earnings Yield	-18.19%	-85.00%	-34.38%	-29.49%	-226.15%	-13.83%
FCF Yield	-15.50%	-77.93%	-38.59%	-36.92%	-239.82%	-11.39%
Buyback Yield / Dilution	-58.45%	-84.14%	-9.80%	-9.33%	-20.72%	-20.63%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.